<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03640468</url>
  </required_header>
  <id_info>
    <org_study_id>N-128-2018</org_study_id>
    <nct_id>NCT03640468</nct_id>
  </id_info>
  <brief_title>Lidocaine as an Adjuvant for Ketamine in Induction of Anesthesia in Septic Shock Patients</brief_title>
  <official_title>Lidocaine as an Adjuvant for Ketamine in Induction of Anesthesia in Septic Shock Patients: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the work is to investigate the effect of using lidocaine in combination with low
      dose ketamine in induction of anesthesia for septic shock patients compared to normal dose of
      ketamine.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Most of the drugs used for induction of anesthesia negatively impact patient hemodynamics.
      Thus, induction of anesthesia in shocked patients might result in deleterious hypotension.
      Patients with severe sepsis and septic shock frequently need surgical interventions. The best
      protocol for induction of anesthesia in septic shock patients is lacking.

      Ketamine is an agent used for induction of anesthesia with known positive cardiovascular
      effects. However, these positive effects were reported in individuals with intact sympathetic
      nervous system. Invitro studies showed that ketamine direct action on the cardiac muscles is
      negative. Thus, it had been recommended that ketamine should be used with caution in
      hemodynamically vulnerable patients till further randomized controlled trials are present.

      Lidocaine is a drug with multiple local and systemic uses. Having local anesthetic
      properties, lidocaine was proposed to have an anesthetic sparing effect. Lidocaine was
      previously reported to enhance the hypnotic effect of thiopentone, propofol, and midazolam
      during induction of anesthesia. Lidocaine showed a sparing effect for volatile as well as
      intravenous requirements for maintenance of anesthesia; thus, we hypothesize that its use as
      an adjuvant during induction of anesthesia in septic shock patient could provide a sparing
      effect for ketamine and minimize its negative circulatory sequelae.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 20, 2018</start_date>
  <completion_date type="Anticipated">July 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">June 15, 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean arterial pressure</measure>
    <time_frame>10 minutes after induction of general anesthesia</time_frame>
    <description>Mean arterial pressure measured in mmHg</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>10 minutes after induction of general anesthesia</time_frame>
    <description>number of heart beats per minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac output</measure>
    <time_frame>10 minutes after induction of general anesthesia</time_frame>
    <description>volume of blood pumped by the heart in one minute measured in liters per minute</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The number of patients who suffer from decreased mean arterial pressure by 20% from the baseline reading after induction of anesthesia</measure>
    <time_frame>10 minutes after induction of general anesthesia</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Norepinephrine consumption</measure>
    <time_frame>10 minutes after induction of general anesthesia</time_frame>
    <description>The total dose of norepinephrine measured in micrograms</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Septic Shock</condition>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Ketamine group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group will receive induction of anesthesia using ketamie full dose 1 mg/kg, midazolam 0.05 mg/Kg, and normal saline 10 mL.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lidocaine-ketamine group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will receive induction of anesthesia using Ketamie half dose 0.5 mg/kg, midazolam 0.05 mg/Kg, and lidocaine 1 mg/Kg.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine full dose</intervention_name>
    <description>This group will receive induction of anesthesia using Ketamine 1 mg/Kg</description>
    <arm_group_label>Ketamine group</arm_group_label>
    <other_name>Ketamine hydrochloride</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine half dose</intervention_name>
    <description>This group will receive induction of anesthesia using Ketamine 0.5 mg/Kg</description>
    <arm_group_label>Lidocaine-ketamine group</arm_group_label>
    <other_name>Ketamine Hydrochloride</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine</intervention_name>
    <description>This group will receive lidocaince 1 mg/Kg</description>
    <arm_group_label>Lidocaine-ketamine group</arm_group_label>
    <other_name>Lidocaine Hydrochloride</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Midazolam</intervention_name>
    <description>This group will receive midazolam 0.05 mg/Kg</description>
    <arm_group_label>Ketamine group</arm_group_label>
    <arm_group_label>Lidocaine-ketamine group</arm_group_label>
    <other_name>Dormicum</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal saline</intervention_name>
    <description>This group will receive normal saline 10 mL</description>
    <arm_group_label>Ketamine group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients aged above 18 years

          -  With septic shock

          -  Scheduled for general anesthesia

        Exclusion Criteria:

          -  Patients under 18 years

          -  Burn patients
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ahmed Hasanin, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistant professor of anesthesia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sarah Amin, Lecturer</last_name>
    <phone>+201227476617</phone>
    <email>sarahamin_22@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cairo University</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>August 18, 2018</study_first_submitted>
  <study_first_submitted_qc>August 20, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 21, 2018</study_first_posted>
  <last_update_submitted>November 20, 2018</last_update_submitted>
  <last_update_submitted_qc>November 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Ahmed Hasanin</investigator_full_name>
    <investigator_title>Assistant professor of anesthesia and critical care</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shock, Septic</mesh_term>
    <mesh_term>Shock</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Midazolam</mesh_term>
    <mesh_term>Ketamine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

